Virtual reality may ease Pre-Surgery anxiety in breast cancer patients

NCT ID NCT07785245

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This pilot trial tests whether a brief virtual reality (VR) experience can help breast cancer patients feel calmer in the waiting period just before surgery. Sixty women scheduled for breast cancer surgery will be randomly assigned to either an 8-minute guided mindfulness meditation in a virtual beach setting, an 8-minute immersive nature scene without guidance, or standard care. The study focuses on whether the VR approach is feasible and acceptable, and also measures changes in anxiety levels before and after the intervention.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Immersive virtual reality mindfulness meditation or immersive nature virtual reality
What this could lead to
If effective, this could offer a drug-free way to calm breast cancer patients' anxiety in the moments before surgery, improving their experience without medication.
What could go wrong
This is a small pilot study focused on feasibility and tolerability, not proof of effectiveness. Some people may feel cybersickness or dizziness from the VR headset, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Female patients aged 18 years or older Capable of providing written informed consent Scheduled for elective breast cancer surgery requiring general anaesthesia Possessing sufficient vision and hearing to engage with the VR experience Exclusion Criteria: Severe visual or auditory impairments Cognitive deficits that would preclude engagement with the VR hardware A history of motion sickness or known contraindications to VR exposure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Champalimaud Foundation - Breast Unit

    Lisbon, Lisbon District, 1400-038, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.